UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Amedisys - Amedisys (NASDAQ:AMED)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

In a report published Friday, Jefferies & Company reiterated its Hold rating on Amedisys (NASDAQ: AMED), but lowered its price target from $14.00 to $9.00.Jefferies noted, “While we continue to believe that home nursing -- being the lowest-cost pre- and post-acute care option -- will have a key place in the continuum of care longer-term, AMED faces numerous near-term headwinds that will pressure its earnings outlook and the stock's valuation. Until these challenges dissipate, we recommend that investors stay on the sidelines.”Amedisys closed on Thursday at $10.50.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!